Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 2

Results: 15

'Tumor immunology meets oncology (TIMO) VI' from 7th to 8th of May 2010 in Halle, Germany.

Published in:

2011

By:

Quandt, Dagmar;
Massa, Chiara;
Seliger, Barbara

Publication type:

Report

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 227, doi. 10.1007/s00262-010-0933-y

By:

Andersen, Rikke;
Sørensen, Rikke;
Ritter, Cathrin;
Svane, Inge;
Becker, Jürgen;
thor Straten, Per;
Andersen, Mads

Publication type:

Article

Migration and immunological reaction after the administration of αGalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 207, doi. 10.1007/s00262-010-0932-z

By:

Kurosaki, Motoyoshi;
Horiguchi, Shigetoshi;
Yamasaki, Kazuki;
Uchida, Yoshitaka;
Motohashi, Shinichiro;
Nakayama, Toshinori;
Sugimoto, Akira;
Okamoto, Yoshitaka

Publication type:

Article

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 217, doi. 10.1007/s00262-010-0931-0

By:

González-Reyes, Salomé;
Fernández, Jesús;
González, Luis;
Aguirre, Alina;
Suárez, Aurelio;
González, José;
Escaff, Safwan;
Vizoso, Francisco

Publication type:

Article

Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 273, doi. 10.1007/s00262-010-0941-y

By:

Driessens, Gregory;
Nuttin, Lise;
Gras, Alain;
Maetens, Julie;
Mievis, Stephane;
Schoore, Marylène;
Velu, Thierry;
Tenenbaum, Liliane;
Préat, Véronique;
Bruyns, Catherine

Publication type:

Article

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 261, doi. 10.1007/s00262-010-0935-9

By:

Oudard, Stéphane;
Rixe, Olivier;
Beuselinck, Benoit;
Linassier, Claude;
Banu, Eugeniu;
Machiels, Jean-Pascal;
Baudard, Marion;
Ringeisen, François;
Velu, Thierry;
Lefrere-Belda, Marie-Aude;
Limacher, Jean-Marc;
Fridman, W.;
Azizi, Michel;
Acres, Bruce;
Tartour, Eric

Publication type:

Article

Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 153, doi. 10.1007/s00262-010-0946-6

By:

Maes, Wim;
Gool, Stefaan

Publication type:

Article

CD8 Co-receptor promotes susceptibility of CD8 T cells to transforming growth factor-β (TGF-β)-mediated suppression.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 291, doi. 10.1007/s00262-010-0962-6

By:

Zloza, Andrew;
Jagoda, Michael;
Lyons, Gretchen;
Graves, Michael;
Kohlhapp, Frederick;
O'Sullivan, Jeremy;
Lacek, Andrew;
Nishimura, Michael;
Guevara-Patiño, José

Publication type:

Article

IL-21-treated naive CD45RA CD8 T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 235, doi. 10.1007/s00262-010-0936-8

By:

Albrecht, Jana;
Frey, Michaela;
Teschner, Daniel;
Carbol, Alexander;
Theobald, Matthias;
Herr, Wolfgang;
Distler, Eva

Publication type:

Article

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 249, doi. 10.1007/s00262-010-0942-x

By:

Lesterhuis, W.;
Schreibelt, Gerty;
Scharenborg, Nicole;
Brouwer, H.;
Gerritsen, Marie-Jeanne;
Croockewit, Sandra;
Coulie, Pierre;
Torensma, Ruurd;
Adema, Gosse;
Figdor, Carl;
Vries, I.;
Punt, Cornelis

Publication type:

Article

CDR2 antigen and Yo antibodies.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 283, doi. 10.1007/s00262-010-0943-9

By:

Totland, Cecilie;
Aarskog, Nina;
Eichler, Tilo;
Haugen, Mette;
Nøstbakken, Jane;
Monstad, Sissel;
Salvesen, Helga;
Mørk, Sverre;
Haukanes, Bjørn;
Vedeler, Christian

Publication type:

Article

Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 161, doi. 10.1007/s00262-010-0929-7

By:

Kuball, Jürgen;
Boer, Karin;
Wagner, Eva;
Wattad, Mohammed;
Antunes, Edite;
Weeratna, Risini;
Vicari, Alain;
Lotz, Carina;
Dorp, Suzanne;
Hol, Samantha;
Greenberg, Philip;
Heit, Wolfgang;
Davis, Heather;
Theobald, Matthias

Publication type:

Article

Primed tumor-reactive multifunctional CD62L human CD8 T cells for immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 173, doi. 10.1007/s00262-010-0928-8

By:

Wölfl, Matthias;
Merker, Katharina;
Morbach, Henner;
Gool, Stefaan;
Eyrich, Matthias;
Greenberg, Philip;
Schlegel, Paul

Publication type:

Article

Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 187, doi. 10.1007/s00262-010-0934-x

By:

Warrington, Richard;
Lewis, Keith

Publication type:

Article

Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 197, doi. 10.1007/s00262-010-0927-9

By:

Vergati, Matteo;
Cereda, Vittore;
Madan, Ravi;
Gulley, James;
Huen, Ngar-Yee;
Rogers, Connie;
Hance, Kenneth;
Arlen, Philip;
Schlom, Jeffrey;
Tsang, Kwong

Publication type:

Article